The CREB3L2 antibody is a polyclonal immunoglobulin G (IgG) antibody designed to detect the CREB3L2 protein, a non-canonical unfolded protein response (UPR) transcription factor. CREB3L2 belongs to the OASIS family, which regulates stress-induced gene expression in the endoplasmic reticulum (ER) and Golgi apparatus . Its N-terminal fragment functions as a transcription factor, while the C-terminal fragment is secreted and implicated in immune modulation .
CREB3L2 promotes triple-negative breast cancer (TNBC) progression by suppressing CD8+ T cell activation via the Hedgehog pathway . Antibody-based studies confirm its overexpression in TNBC and correlation with reduced CD8+ T cell infiltration .
CREB3L2 regulates long-lived plasma cell (LLPC) survival by controlling CD28/SLP-76 and CD93 expression . Antibody-mediated detection is critical for validating these findings .